Financhill
Sell
49

OCX Quote, Financials, Valuation and Earnings

Last price:
$3.30
Seasonality move :
-17.73%
Day range:
$3.26 - $3.35
52-week range:
$1.92 - $4.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
14.73x
P/B ratio:
9.10x
Volume:
38.2K
Avg. volume:
45.4K
1-year change:
23.79%
Market cap:
$92.9M
Revenue:
$1.9M
EPS (TTM):
-$3.53

Earnings Data

Next earnings date for OCX
Aug 08
2025
Most recent earnings per share
-$0.26
Missed by $0.01
(May 12/2025)
Consensus Estimate
-$0.25
(May 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

OCX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $292K -- -- -$0.24 --
05/12/2025 Q1 $126.8K $2.1M -$0.26 -$0.25 -$0.01
03/24/2025 Q4 $101.7K $1.5M -$1.93 -- --
11/12/2024 Q3 $168.3K $115K -$0.98 -- --
08/08/2024 Q2 $312.4K $104K -$0.36 -$0.37 $0.01
05/15/2024 Q1 $350K $176K -$1.13 -$0.57 -$0.56
03/29/2024 Q4 $316.7K $314K -$2.07 -- --
11/09/2023 Q3 $312.5K $429K -$0.81 -$0.78 -$0.03
08/10/2023 Q2 $350K $463K -$1.07 -$0.59 -$0.48
05/11/2023 Q1 -- $297K $0.40 -- --
03/31/2023 Q4 -- $274K -$8.03 -- --
11/10/2022 Q3 -- $67K -$1.62 -- --
08/10/2022 Q2 -- $237K -$1.48 -- --
05/11/2022 Q1 -- $380K -$2.20 -- --
03/10/2022 Q4 -- -$1.9M -$7.80 -- --
11/09/2021 Q3 -- $984K -$3.00 -- --
08/10/2021 Q2 -- $2M -$2.40 -- --
05/17/2021 Q1 -- $1.1M -$1.00 -- --
03/16/2021 Q4 -- $503K -$1.80 -- --
11/12/2020 Q3 -- $555K -$2.00 -- --
07/29/2020 Q2 -- $143K -$2.80 -- --
05/12/2020 Q1 -- $16K -$2.60 -- --
03/25/2020 Q4 -- -- -$3.00 -- --
11/14/2019 Q3 -- -- -$2.00 -- --
08/14/2019 Q2 -- -- -$2.07 -- --
04/01/2019 Q1 -- -- -$1.60 -- --
12/31/2018 Q4 -- -- -$2.20 -- --
11/13/2018 Q3 -- -- -$1.40 -- --
08/14/2018 Q2 -- -- -$2.40 -- --
04/02/2018 Q1 -- -- -$2.40 -- --
12/31/2017 Q4 -- -- -$2.60 -- --
11/14/2017 Q3 -- -- -$4.40 -- --
08/14/2017 Q2 -- -- -$2.60 -- --
03/31/2017 Q1 -- -- -$3.20 -- --
12/31/2016 Q4 -- -- -$2.20 -- --
09/30/2016 Q3 -- -- -$2.00 -- --
06/30/2016 Q2 -- -- -$2.00 -- --
03/31/2016 Q1 -- -- -$2.40 -- --
12/31/2015 Q4 -- -- -$2.80 -- --
09/30/2015 Q3 -- -- -$1.90 -- --
06/30/2015 Q2 -- -- -$4.35 -- --

OncoCyte Earnings Questions

  • How Much did OncoCyte Generate in Revenue Last Quarter?

    OncoCyte reported $2.1M worth of top line sales in its most recent quarter.

  • Did OncoCyte Beat Earnings Last Quarter?

    OncoCyte announced earnings per share of -$0.26 which represents a miss of analyst forecast a -$0.25 per share.

  • Is OncoCyte Profitable?

    OncoCyte reported $1.3M that represents $0.05 per share over the last quarter.

  • What is the Analyst Consensus for OncoCyte EPS Next Year?

    OncoCyte's earnings are forecast to decrease from -$4.66 per share to -$0.99 per share next year representing a decrease of -78.76%.

  • When is OncoCyte's Earnings Date?

    OncoCyte's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
58
TNXP alert for May 28

Tonix Pharmaceuticals Holding [TNXP] is up 1.57% over the past day.

Buy
70
AGFY alert for May 29

Agrify [AGFY] is up 18.95% over the past day.

Buy
88
SMR alert for May 28

NuScale Power [SMR] is down 0.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock